Author: admin

Our elders give a remarkable life.

|

our elders give a remarkable life.

On the occasion of the world day of older people, the October 1.

-What are happy is their family situation, free time which they have and their State of health, therefore, Laboratorios Indas continues to innovate to improve the quality of life of those suffering from one of the problems that most affect them: urinary incontinence.

Spain, September 2009.- In Spain there is 7.6 million people older than 65 years, of which more than two million are octogenarians, in fact, it is the second country with greater ageing of the population, behind Japan. Between 2005 and 2050 the Spanish population over 65 will increase from 16.8% to 33.2%. , according to the 2008 report on the elderly, driven by the Observatory of the Imserso.

In the world day of older people, Indas Institute launches an optimistic message, and insists that the ageing of the population should not be understood as a problem, but as the logical consequence of a society with a life expectancy higher than ever. The key: maintain an acceptable quality of life.

In fact, are increasingly those that opt for continue an active life after age 65: half says walking or exercising daily, 26% get the weekend with friends and are increasingly engaged in artistic activities, or point to accredited educational activities, especially women (10.5%).

Winning the battle to urinary incontinence

One of the problems that influence and affect the quality of life of older persons in Spain is the incontinence of urine (IO). In figures, 1 in 2 women and 1 out of 3 men over 65 years and who live in larger centres suffer from this disease and suffering leaks daily, according to the study population of incontinence burden and cost (EPICC), driven by the Spanish Association of urology and directed by Dr. Eduardo Martínez AgullóHead of the unit of Neurourología and urodynamic of Hospital La Fe of Valencia and coordinator of the Scientific Committee of the Indas Institute.

This disease affects all areas of the patient’s life: personal, work, family, social and psychological. According to the seriousness and circumstances, those who suffer from it, you can see deteriorated his image, his personality and habits. And in many cases is assumed to be an embarrassing condition of age, causing an extreme limitation of activity, social isolation, anxiety, depression and sexual dysfunction.

Laboratorios Indas.

Company committed to the promotion of better health, aims to help improve public health and the quality of life of persons suffering from urinary incontinence in Spain. To this end, in 2008, it launched the Indas Institute in order to inform, train and educate both the collective health and society in general, and patients and caregivers in particular.

In parallel, Laboratorios Indas contributes to improving the quality of life for incontinent people with a wide range of products adapted to the needs and circumstances of those who suffer from IO, as well as the hospitals and residences: –incopack and Indaslip, to severe incontinence; Indasec, for mild losses; Indasbed and Sabanindas for patients restrain for inbed incontinent.

Read More

One of every four primary care consultations regarding symptoms of unknown origin.

|

one of every four primary care consultations regarding symptoms of origin unknown.

‘ Epidemic ’ disease “ phantom ”.

-a person suffers from somatizaciones when you have one or more symptoms, and after a medical examination, these symptoms can not be explained by a disease organic.

-Nahia San Pedro, psychologist of AMSA says that “ every human being is a part of the body more vulnerable, it is here where it appears the disease, which has its origin in a psychological imbalance ”.

-psychosomatic diseases often associated with anxious, depressive episodes, and disorders of personality, among others.

-hypertension, peptic ulcer, irritable colon, neurodermatitis, ulcerative colitis, rheumatoid arthritis and bronchial asthma are some diseases which suspected that the psychological factor can have great importance.

-the expert advocates a treatment that integrates the physical and psychological, i.e., “ care and deepen the mind-body relation ”.

Bilbao, September 2009.- The maximum Mens sana in corpore sano evidence the close link between the mind and body. In the same way that many physical diseases affect our State of mind and provoke us fear, fear and concern, many psychological problems cause physical symptoms.

In effect, psychosomatic diseases are very common. So much so, some studies suggest that nearly 12% of the European population suffers these annoyances, and considered that a quarter of the people who come to the primary care physician have such diseases.

In general terms refers to a person suffers from somatizaciones when you have one or more symptoms, and after a medical examination these symptoms can not be explained by an organic disease. According to Nahia San Pedro Santana, AMSA psychologist specialist in dance movement therapy, psychosomatic disease has as origin “ a psycho-emotional disorder that crossed the barrier of the body and generates real diseases ”.

The expert refutes the false belief that such diseases have no real physical symptoms. “ On occasion I have treated patients with ulcers of the stomach with vomiting, and bleeding whose origin was not organic, but psychic ”. St. Peter says that “ every human being is a part of the body more vulnerable, it is here where it appears the disease ”.

Associated pathology

This type of pathology also tend to go associated in many cases to other types of mental illness. “ We can affirm that psychosomatic diseases are usually linked with anxious, depressive episodes, and even with disorders of personality, among others ”.

There are also a number of diseases “ physical ” in which suspected that the psychosomatic factor can have great importance. These are: hypertension, peptic ulcer, irritable colon, neurodermatitis, rheumatoid arthritis and ulcerative colitis, bronchial asthma.

The root of the problem is therefore “ a mental imbalance, a fragmentation between the psychic and physical ”. To find out, many patients are authentic “ pilgrimages ” by different specialists which fail to give the nail on the head because “ organic treatments not only heal psychosomatic diseases ”.

Harmony body/mind

The AMSA psychologist calls for care for the mind-body relationship. To treat these disorders, explains, “ the first thing is to come into contact with our body through a process of bodily awareness through movement, dance, and auto-masaje ”. The aim is to “ integrate the physical and psychological ”, adds.

On the other hand, “ increasingly is diagnosed more and increasingly doctors derive more psychologists ”. In fact, are slowly breaking schools of Psychosomatic Medicine, “ something very new in our country ”, according to the expert said.

To recognize these diseases, Saint Peter says that often “ until that professional treatment administered by the doctor does not fail, there is no referral ”. However, “ increasingly there are more people that goes directly to the psychologist ”, hue.

Read More

Zeldox ® receives European approval for the treatment of bipolar disorder in children and adolescents.

|

Zeldox ® receives the European approval for the treatment of bipolar in children and adolescents. disorder

According to the procedure of mutual recognition European.

– the new indication will be made effective in 12 European countries, which include Spain.

– En Spain is estimated that some 800,000 people could suffer this disorder throughout his life.

– particularly in the last years of adolescence or in the early-age adult.

Madrid, September 2009.- The Swedish Medicines Agency (MPA, its acronym in English) has approved ziprasidone (Zeldox ®) for the treatment of moderately manic or mixed episodes associated with bipolar disorder in children and adolescents aged 10 to 17. The procedure of European mutual recognition, in which the Swedish Agency acting as reference Member State, has been completed, so the approval in the rest of the 12 European countries will arrive soon.

The adoption of the Swedish Agency of medicinal products is based on the results of a double blind study of 4 weeks, placebo-controlled and in which participated 237 patients aged 10 to 17 years diagnosed with bipolar disorder. The study shows that ziprasidone is an effective treatment for the symptoms of bipolar mania and with a profile similar to the adult safety in children. The majority of patients who received ziprasidone experienced a neutral effect on the body weight on both parameters metabolic, including glucose and lipids.

” Bipolar disorder in young people is a priority health issue for the potential impact on the life of a child or adolescent, as well as their families ” pointed out the Dr. Juan Álvarez, Director of the unit medical of Pfizer. “ addition, there are few treatments for this disease so that this new therapeutic optionIt allows to treat the symptoms of bipolar disorder, it will help children and their families better cope with this disease ”.

Spain estimates that around 800,000 people could suffer from this disorder throughout his life and that if left untreated can affect substantially both in family and social spheres and in the labour.

Bipolar disorder is a serious mental illness characterized by abrupt changes in the State of mood and behavior, affecting especially in late adolescence or early adulthood. When the disease occurs in children or young adolescents is called bipolar illness for home early. In adolescents, the fluctuations of mood, which alternate with maniacs and depressive, episodes are characterized by euphoria, unrealistic increases in self-esteem, and decreased sleep, along with a high-risk behaviors such as alcohol, drug abuse, reckless driving and sexual promiscuity.

With more than seven years of experience, ziprasidone is available in 77 countries around the world. In the European Union, ziprasidone has already been approved for the treatment of adults with schizophrenia and manic or mixed episodes of bipolar disorder treatment. The procedure of European mutual recognition, whereby Zeldox ® has been approved to treat bipolar mania in children and adolescents, applies in the following countries: Spain, Austria, Denmark, Finland, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Norway, Portugal and Sweden.

Pfizer, “ working together for a world more sanoTM ”

Founded in 1849, Pfizer is the largest biomedical company that encourages new initiatives to promote health. At Pfizer, we discover, develop and make available patient and professional health medications effective, safe and quality, to treat and help prevent diseases, of persons and animals. Also, we work with professionals and health authorities to ensure access to our medicines and to provide better health care and support to health systems. At Pfizer, all partners work every day to help people to live a healthier life and to enjoy better quality of life.

Read More
On 12 October surgeons implanted an artificial heart as permanent circulatory assistance.

On 12 October surgeons implanted an artificial heart as permanent circulatory assistance.

|

October 12 surgeons implanted an artificial heart as circulatory assistance permanent.

Fernández-Lasquetty attends the presentation of this intervention.

– is indicated for people with refractory heart failure not candidates for transplantation

– This is the first patient in Spain that receives the discharge with a ultimate continuous flow device

– in 1996 the hospital pioneered by placing a device implantable left ventricular assistance

Spain, 2011-August the team of specialists of surgery Cardiaca in the Hospital Universitario 12 de Octubre Madrid service has been implemented with successful permanent artificial heart – unlike other temporary systems which are removed when a transplant. The presentation of this intervention has attended the Health Minister, Javier Fernández – Lasquetty.

Specifically, it’s a permanent continuous flow left ventricular assist device, placed a patient from 67 years of age for the first time in Spain has been discharged from hospital just a month after the intervention. This time is considered very low for such devices, according to underline the surgeons.

“ With this project, hospital 12 October takes a step in its commitment to excellence, both in assisting patients in teaching and research, slopes which places their health professionals in the focus of the health innovation world ”, assured Fernández-Lasquetty.

the patient suffered from dilated cardiomyopathy – the muscle of the heart was not able to effectively – contract, due to a prior heart attack and not was heart transplant candidate to present simultaneously nonreversible renal failure and chronic obstructive pulmonary disease – COPD-moderate. Comply correctly with pharmacotherapy to maximum, their functional situation before intervention was limit, with a minimum capacity to carry out efforts and recurring revenues by heart failure requiring intravenous medication to normalize their clinical situation.

After the intervention he stayed four days in care Postoperatorios of cardiac surgery – UCP – unit and was later transferred to the plant of hospitalization of Cardiology, where he began the mobilization, rehabilitation and learning the operation of the device to be registered within 30 days of the implant. Currently, it presents a very satisfactory general condition and has resumed its activity daily with a weekly medical supervision during the first and second month, and monthly thereafter.

To ensure the success of the process, this health center cardiology and cardiac surgery services specialists have participated for more than three years in theoretical and practical training plans and the development of a joint programme of permanent circulatory assistance.

Details of the device

The medical team decided to implement a ventricular assist device based on clinical criteria, to present the patient a plight hemodynamics with all medical treatments and exhausted support. Such systems may be indicated on a temporary basis, until the recovery hemodynamics and myocardial and as a bridge to heart transplantation, or definitively not transplantable as this is where.

The device used in the October 12 consists of an axial-flow pump driven way electromagnetic and composed a motor-bomba, cannula entry and exit, and a control unit. This pump boosts the blood from the apex of the left ventricle – the tip of the heart – to the aorta. The turbine that contains rotates at a speed of between 6,000 and 15,000 revolutions per minute and can provide 8 to 10 gallons of flow per minute.

The device is located within the patient and just a cable crossing the skin to connect it with the control unit, which works through the mains power or two batteries allowing approximately 12 hours autonomy. Once implanted not precise calibrations or subsequent technical adjustments.

More than 6,500 patients of United States and Europe – none in Spain far – have benefited from this system with a few clinical results higher on other devices, since that reduces the risk of infections, thrombosis and hemolysis – rupture of red blood cells or red blood cells.

Equipment pioneer

On August 11, 1996 the team of cardiac surgeons from the Hospital on October 12 also pioneered Spain to install an autonomous artificial heart in a 66-year-old patient. Diagnosed with a terminal heart failure, it presented a major problem of rejection in his immune system which made it virtually impossible for admission to the heart transplant waiting list.

In that speech was used an electromechanical apparatus of a kilo of weight and size of 15 x 10 cm remained with the deteriorated heart to improve it with a view to a subsequent transplant, pushing the blood from the heart muscle to aortic artery.

Since 1991, year in which began to place devices of ventricular assist in various clinical indications, this Madrid hospital has implemented a total of 95 aircraft of various technologies, a very high figure if one takes into account the limited experience in this type of surgical intervention to level national.

Read More

Russia deck to postpone launch Soyuz manned after disaster with freighter

|

Moscow, 26 Aug (EFE).-Russia deck to postpone the launch of the next Soyuz spacecraft with three crew aboard after the catastrophe with the cargo ship Progress which crashed on Wednesday in Siberia, today reported a source of aerospace Russian.

“It is speaking bring forward the launch of Progress M – 13 M from 28 to 14 October and defer of the Soyuz TMA-22 from September 22 to November”, said the source at the Russian agencies.

In this way, he added, “the cargo ship would be sent to the international space station (ISS) before the manned spacecraft” not to take risks with cosmonauts to Board

The Russian space agency Roscosmos intends to test the operation of the rocket carrying Soyuz-U similar to which failed this week for the launch into orbit of the Progress M – 12 M, carrying nearly three tons of vital cargo to the ISS.

Progress freighters and ships Soyuz carrier rockets are equipped both with engines PD-0110 in its third stage.

Therefore, the current six crew of the orbital platform will have to remain in their jobs longer foreseen.

The expedition consisting of the Russian cosmonauts Alexandr Samokutiáyev and Andrei Borisenko and American Ronald Garan, who arrived in April to space, ingenuity will have to remain, predictably, two weeks at the station.

Meanwhile, Russian Sergei Volkov, American astronaut Michael Fossum and Satosi Furukawa Japanese might have to delay its return to Earth for a month, until the end of year.

Despite the crash of the Russian freighter, the six crew members of the station have enough food, oxygen and fuel to two or three months, so no risk for its work and physical integrity, according to Roscosmos and NASA coincide.

Due to accident, Russia has suspended the activities of the Soyuz rocket, which forced them to postpone the launch of the satellite navigation Glonass-M which was scheduled for today.

The suspension of the Soyuz launches came two days after Roscosmos, the Russian space agency, it announced equal measure with respect to the rocket carriers Proton accelerators blocks Briz-m.

The Prime Minister of Russia, Vladimir Putin, has ordered Roscosmos tougher quality controls in the production of space equipment and parts thereof, especially before its release.

The first accident in the history of Progress, used since 1978, comes three weeks after Russian freighters and Soyuz ships became the only link between the Earth and the ISS, following the retirement of American ferry.EFE

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips